NEWS & VIEWS

Global private equity and venture capital news and research

Bay City Capital captures ex-Amgen executive David Beier as managing director

14 May 2013

David Beier Bay City CapitalLife sciences-focused venture firm Bay City Capital has hired experienced biotech operator David Beier as a managing director.

Beier has spent almost a decade as a senior office in businesses Genentech and Amgen, most recently with the latter as senior vice president for global government affairs.

Earlier in his career he was chief domestic policy advisor to vice president Al Gore during the Clinton Administration.

Bay City founder and managing director Fred Craves said, “Today’s rapidly evolving healthcare industry provides tremendous opportunity for investment both in the United States and globally.

“David brings an extensive government affairs and public policy background, providing unique insights to our investment team.”

Bay City has managed more than $1.6bn across eight venture capital funds since it was launched in 1997.

The firm has invested in over 100 life sciences companies globally including Hyperion Therapeutics, Oculex Pharmaceuticals and Ion Torrent Systems.

It most recently reported investment came in March when it led a $20m Series D financing round for DNA analysis developer Nabsys.

Existing investors including Point Judith Capital and Stata Venture Partners also took part in the round.

Copyright © 2013 AltAssets

FUNDRAISING & INVESTOR RELATIONS

Join the Private Equity & VC Fundraising & IR Group on LinkedIn. For LPs and GPs with an interest in private equity and venture capital fundraising, investor relations and marketing.

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014